Does the media prefer COIN or SI?

In the previous week, Coinbase Global had 52 more articles in the media than Shoulder Innovations. MarketBeat recorded 61 mentions for Coinbase Global and 9 mentions for Shoulder Innovations. Coinbase Global's average media sentiment score of 0.75 beat Shoulder Innovations' score of 0.11 indicating that Coinbase Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Coinbase Global 28 Very Positive mention(s) 11 Positive mention(s) 14 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Positive Shoulder Innovations 0 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to OMCL or SI?

In the previous week, Shoulder Innovations had 2 more articles in the media than Omnicell. MarketBeat recorded 9 mentions for Shoulder Innovations and 7 mentions for Omnicell. Omnicell's average media sentiment score of 1.51 beat Shoulder Innovations' score of 0.11 indicating that Omnicell is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omnicell 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Shoulder Innovations 0 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to SI or ATEC?

In the previous week, Shoulder Innovations had 1 more articles in the media than Alphatec. MarketBeat recorded 9 mentions for Shoulder Innovations and 8 mentions for Alphatec. Alphatec's average media sentiment score of 1.50 beat Shoulder Innovations' score of 0.11 indicating that Alphatec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shoulder Innovations 0 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Alphatec 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Shoulder Innovations (SI) Competitors

$18.41 -0.70 (-3.68%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$18.52 +0.11 (+0.59%)

As of 09/11/2026 07:46 PM Eastern

Compare

SI vs. COIN, OMCL, CNMD, KMTS, and ATEC

Should you buy Shoulder Innovations stock or one of its competitors? Shoulder Innovations's main competitors and comparable companies include Coinbase Global (COIN), Omnicell (OMCL), CONMED (CNMD), Kestra Medical Technologies (KMTS), and Alphatec (ATEC). Companies are selected based on similarities in market, industry, and size.

How does Shoulder Innovations compare to Coinbase Global?

Coinbase Global (NASDAQ:COIN) and Shoulder Innovations (NYSE:SI) are related companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, media sentiment, risk, earnings and profitability.

In the previous week, Coinbase Global had 52 more articles in the media than Shoulder Innovations. MarketBeat recorded 61 mentions for Coinbase Global and 9 mentions for Shoulder Innovations. Coinbase Global's average media sentiment score of 0.75 beat Shoulder Innovations' score of 0.11 indicating that Coinbase Global is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Coinbase Global	28 Very Positive mention(s)	11 Positive mention(s)	14 Neutral mention(s)	5 Negative mention(s)	0 Very Negative mention(s)	Positive
Shoulder Innovations	0 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Coinbase Global has higher revenue and earnings than Shoulder Innovations. Coinbase Global is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Coinbase Global	$6.28B	7.36	$1.26B	-$3.84	N/A
Shoulder Innovations	$47.32M	8.10	-$40.36M	-$1.92	N/A

Coinbase Global has a net margin of -15.72% compared to Shoulder Innovations' net margin of -58.33%. Coinbase Global's return on equity of 3.12% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Coinbase Global	-15.72%	3.12%	1.54%
Shoulder Innovations	-58.33%	-23.61%	-19.53%

Coinbase Global presently has a consensus target price of $218.74, suggesting a potential upside of 24.81%. Shoulder Innovations has a consensus target price of $25.50, suggesting a potential upside of 38.54%. Given Shoulder Innovations' stronger consensus rating and higher probable upside, analysts clearly believe Shoulder Innovations is more favorable than Coinbase Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Coinbase Global	4 Sell rating(s)	11 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.42
Shoulder Innovations	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

Coinbase Global has a beta of 3.39, meaning that its stock price is 239% more volatile than the broader market. Comparatively, Shoulder Innovations has a beta of -1.77, meaning that its stock price is 277% less volatile than the broader market.

68.8% of Coinbase Global shares are owned by institutional investors. 16.7% of Coinbase Global shares are owned by insiders. Comparatively, 29.0% of Shoulder Innovations shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Coinbase Global beats Shoulder Innovations on 10 of the 16 factors compared between the two stocks.

How does Shoulder Innovations compare to Omnicell?

Omnicell (NASDAQ:OMCL) and Shoulder Innovations (NYSE:SI) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.

Omnicell has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omnicell	$1.25B	1.20	$2.05M	$0.84	39.04
Shoulder Innovations	$47.32M	8.10	-$40.36M	-$1.92	N/A

In the previous week, Shoulder Innovations had 2 more articles in the media than Omnicell. MarketBeat recorded 9 mentions for Shoulder Innovations and 7 mentions for Omnicell. Omnicell's average media sentiment score of 1.51 beat Shoulder Innovations' score of 0.11 indicating that Omnicell is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omnicell	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Shoulder Innovations	0 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Omnicell has a net margin of 3.13% compared to Shoulder Innovations' net margin of -58.33%. Omnicell's return on equity of 5.66% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omnicell	3.13%	5.66%	3.57%
Shoulder Innovations	-58.33%	-23.61%	-19.53%

Omnicell currently has a consensus target price of $57.86, suggesting a potential upside of 76.45%. Shoulder Innovations has a consensus target price of $25.50, suggesting a potential upside of 38.54%. Given Omnicell's stronger consensus rating and higher possible upside, equities analysts plainly believe Omnicell is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omnicell	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Shoulder Innovations	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

97.7% of Omnicell shares are held by institutional investors. 2.9% of Omnicell shares are held by insiders. Comparatively, 29.0% of Shoulder Innovations shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Omnicell has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market. Comparatively, Shoulder Innovations has a beta of -1.77, indicating that its stock price is 277% less volatile than the broader market.

Summary

Omnicell beats Shoulder Innovations on 13 of the 16 factors compared between the two stocks.

How does Shoulder Innovations compare to CONMED?

CONMED (NYSE:CNMD) and Shoulder Innovations (NYSE:SI) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability and earnings.

CONMED has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market. Comparatively, Shoulder Innovations has a beta of -1.77, suggesting that its share price is 277% less volatile than the broader market.

In the previous week, Shoulder Innovations had 9 more articles in the media than CONMED. MarketBeat recorded 9 mentions for Shoulder Innovations and 0 mentions for CONMED. CONMED's average media sentiment score of 1.81 beat Shoulder Innovations' score of 0.11 indicating that CONMED is being referred to more favorably in the media.

Company	Overall Sentiment
CONMED	Very Positive
Shoulder Innovations	Neutral

CONMED has a net margin of 4.12% compared to Shoulder Innovations' net margin of -58.33%. CONMED's return on equity of 14.31% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.12%	14.31%	6.33%
Shoulder Innovations	-58.33%	-23.61%	-19.53%

CONMED presently has a consensus target price of $41.40, suggesting a potential downside of 10.29%. Shoulder Innovations has a consensus target price of $25.50, suggesting a potential upside of 38.54%. Given Shoulder Innovations' stronger consensus rating and higher possible upside, analysts plainly believe Shoulder Innovations is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	2 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75
Shoulder Innovations	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

CONMED has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	1.01	$47.06M	$1.85	24.95
Shoulder Innovations	$47.32M	8.10	-$40.36M	-$1.92	N/A

Summary

CONMED beats Shoulder Innovations on 9 of the 14 factors compared between the two stocks.

How does Shoulder Innovations compare to Kestra Medical Technologies?

Kestra Medical Technologies (NASDAQ:KMTS) and Shoulder Innovations (NYSE:SI) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

Kestra Medical Technologies has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market. Comparatively, Shoulder Innovations has a beta of -1.77, meaning that its share price is 277% less volatile than the broader market.

Shoulder Innovations has a net margin of -58.33% compared to Kestra Medical Technologies' net margin of -138.35%. Shoulder Innovations' return on equity of -23.61% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%
Shoulder Innovations	-58.33%	-23.61%	-19.53%

Shoulder Innovations has lower revenue, but higher earnings than Kestra Medical Technologies. Shoulder Innovations is trading at a lower price-to-earnings ratio than Kestra Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kestra Medical Technologies	$95.13M	14.08	-$131.61M	-$2.42	N/A
Shoulder Innovations	$47.32M	8.10	-$40.36M	-$1.92	N/A

Kestra Medical Technologies presently has a consensus target price of $28.14, indicating a potential upside of 23.16%. Shoulder Innovations has a consensus target price of $25.50, indicating a potential upside of 38.54%. Given Shoulder Innovations' stronger consensus rating and higher probable upside, analysts plainly believe Shoulder Innovations is more favorable than Kestra Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Shoulder Innovations	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

In the previous week, Kestra Medical Technologies had 8 more articles in the media than Shoulder Innovations. MarketBeat recorded 17 mentions for Kestra Medical Technologies and 9 mentions for Shoulder Innovations. Kestra Medical Technologies' average media sentiment score of 0.26 beat Shoulder Innovations' score of 0.11 indicating that Kestra Medical Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kestra Medical Technologies	7 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Shoulder Innovations	0 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Shoulder Innovations beats Kestra Medical Technologies on 8 of the 14 factors compared between the two stocks.

How does Shoulder Innovations compare to Alphatec?

Shoulder Innovations (NYSE:SI) and Alphatec (NASDAQ:ATEC) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

In the previous week, Shoulder Innovations had 1 more articles in the media than Alphatec. MarketBeat recorded 9 mentions for Shoulder Innovations and 8 mentions for Alphatec. Alphatec's average media sentiment score of 1.50 beat Shoulder Innovations' score of 0.11 indicating that Alphatec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shoulder Innovations	0 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alphatec	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

66.3% of Alphatec shares are held by institutional investors. 29.0% of Shoulder Innovations shares are held by company insiders. Comparatively, 13.5% of Alphatec shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Shoulder Innovations presently has a consensus price target of $25.50, indicating a potential upside of 38.54%. Alphatec has a consensus price target of $17.40, indicating a potential upside of 64.46%. Given Alphatec's stronger consensus rating and higher possible upside, analysts clearly believe Alphatec is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67
Alphatec	1 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.80

Alphatec has a net margin of -13.49% compared to Shoulder Innovations' net margin of -58.33%. Shoulder Innovations' return on equity of -23.61% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-58.33%	-23.61%	-19.53%
Alphatec	-13.49%	-6,752.24%	-13.88%

Shoulder Innovations has a beta of -1.77, meaning that its stock price is 277% less volatile than the broader market. Comparatively, Alphatec has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market.

Shoulder Innovations has higher earnings, but lower revenue than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	8.10	-$40.36M	-$1.92	N/A
Alphatec	$815.05M	2.00	-$143.36M	-$0.71	N/A

Summary

Alphatec beats Shoulder Innovations on 10 of the 16 factors compared between the two stocks.

Get Shoulder Innovations News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SI vs. The Competition

Export

Metric	Shoulder Innovations	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$397.85M	$5.38B	$7.13B	$23.17B
Dividend Yield	N/A	1.79%	2.56%	3.56%
P/E Ratio	-9.59	25.09	275.24	28.71
Price / Sales	8.10	82.90	656.02	94.44
Price / Cash	N/A	32.53	77.04	33.82
Price / Book	2.69	5.97	10.33	4.74
Net Income	-$40.36M	$150.75M	$3.50B	$1.07B
7 Day Performance	-9.46%	-2.83%	-3.32%	-2.00%
1 Month Performance	-4.93%	-3.09%	-0.41%	-2.69%
1 Year Performance	17.09%	9.34%	19.21%	10.45%

Shoulder Innovations Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SI Shoulder Innovations	2.9349 of 5 stars	$18.41 -3.7%	$25.50 +38.5%	+23.4%	$397.85M	$47.32M	N/A	61	News Coverage Gap Up
COIN Coinbase Global	3.3708 of 5 stars	$184.64 -4.2%	$216.87 +17.5%	-45.9%	$50.84B	$7.18B	N/A	4,951	Trending News Analyst Upgrade Insider Trade
OMCL Omnicell	4.4201 of 5 stars	$34.37 -1.3%	$57.86 +68.3%	-1.5%	$1.58B	$1.18B	40.92	3,580	Positive News
CNMD CONMED	1.9662 of 5 stars	$48.97 -0.9%	$41.40 -15.5%	-14.6%	$1.48B	$1.37B	26.47	3,900	Positive News Gap Up
KMTS Kestra Medical Technologies	2.1693 of 5 stars	$25.54 +1.6%	$28.14 +10.2%	+24.2%	$1.47B	$95.13M	N/A	300	Trending News Analyst Downgrade Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:SI) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Shoulder Innovations (SI) Competitors

SI vs. COIN, OMCL, CNMD, KMTS, and ATEC

How does Shoulder Innovations compare to Coinbase Global?

Summary

How does Shoulder Innovations compare to Omnicell?

Summary

How does Shoulder Innovations compare to CONMED?

Summary

How does Shoulder Innovations compare to Kestra Medical Technologies?

Summary

How does Shoulder Innovations compare to Alphatec?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SI vs. The Competition

Shoulder Innovations Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Shoulder Innovations (SI) Competitors

SI vs. COIN, OMCL, CNMD, KMTS, and ATEC

How does Shoulder Innovations compare to Coinbase Global?

Does the media prefer COIN or SI?

Which has preferable valuation & earnings, COIN or SI?

Is COIN or SI more profitable?

Do analysts prefer COIN or SI?

Which has more volatility and risk, COIN or SI?

Do insiders & institutionals have more ownership in COIN or SI?

Summary

How does Shoulder Innovations compare to Omnicell?

Which has better valuation & earnings, OMCL or SI?

Does the media refer more to OMCL or SI?

Is OMCL or SI more profitable?

Do analysts recommend OMCL or SI?

Do insiders & institutionals have more ownership in OMCL or SI?

Which has more risk & volatility, OMCL or SI?

Summary

How does Shoulder Innovations compare to CONMED?

Which has more risk and volatility, CNMD or SI?

Does the media refer more to CNMD or SI?

Is CNMD or SI more profitable?

Do analysts prefer CNMD or SI?

Which has stronger earnings and valuation, CNMD or SI?

Summary

How does Shoulder Innovations compare to Kestra Medical Technologies?

Which has more volatility and risk, KMTS or SI?

Is KMTS or SI more profitable?

Which has better valuation and earnings, KMTS or SI?

Do analysts recommend KMTS or SI?

Does the media prefer KMTS or SI?

Summary

How does Shoulder Innovations compare to Alphatec?

Does the media refer more to SI or ATEC?

Do institutionals & insiders hold more shares of SI or ATEC?

Do analysts recommend SI or ATEC?

Is SI or ATEC more profitable?

Which has more volatility and risk, SI or ATEC?

Which has stronger earnings & valuation, SI or ATEC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SI vs. The Competition

Shoulder Innovations Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools